Drawing for UNLEARN

USPTO serial 88830893

UNLEARN

Reviewed by CopyMark Law Group

Reg. 6168042Status 700Renewal
Filing date
Status date
Registration date
Oct 6, 2020
Examiner
MONDELL, DOUGLAS
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with UNLEARN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $748*

Plus Government fees of $850

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Isaac M. Fine

Isaac M. Fine KPPB LLP180 E. Ocean Blvd., Suite 1030Long Beach, CA 90802United States

Goods and services

ClassDescriptionStatusFirst use
035business consulting and management in the fields of medical research, pharmaceutical development and clinical trials for business purposes; business consulting and management in the field of clinical trials, namely, management and compilation of computerized databases in the field of clinical trials for business purposes; business consulting and management in the field of pharmaceutical development, namely, management and compilation of computerized databases in the field of pharmaceutical development for business purposes; business consulting and management in the field of pharmaceutical development, namely, management and compilation of computerized databases in the field of medical research for business purposesACTIVE—
042providing medical and scientific research information in the fields of medical research, pharmaceutical development and clinical trials; consulting services for others in the field of design and planning of clinical trials; consulting services for others in the fields of medical research and pharmaceutical development; consulting services for others in the fields of medical research and pharmaceutical development, namely, providing digital models of patients for use as simulated control subjects; consulting services for others in the field of design and planning of clinical trials, namely, providing digital models of patients for use as simulated control subjects for clinical trials; providing data analytics and artificial intelligence in the nature of providing temporary use of online non-downloadable software for use in the design and planning of clinical trials; providing data analytics and artificial intelligence in the nature of providing temporary use of online non-downloadable software for use in medical research and pharmaceutical development; providing data analytics and artificial intelligence in the nature of providing temporary use of online non-downloadable software for use in the life sciences field for the purpose of research, development, and commercialization; providing temporary use of on-line non-downloadable cloud computing software for managing, gathering, generating, organizing, and sharing data in the fields of pharmaceutical development, medical clinical trials and medical research; providing temporary use of on-line non-downloadable cloud computing software for designing, managing, and executing medical clinical trials and medical research and medical clinical trial and medical research protocols; providing temporary use of on-line non-downloadable cloud computing software for designing, managing, and executing pharmaceutical development research; providing a website featuring educational information in the fields of medical research, pharmaceutical development, clinical trials and artificial intelligenceACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 21, 2026E815TEAS SECTION 8 & 15 RECEIVED—
Dec 12, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Dec 12, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 12, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Oct 6, 2025REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Apr 22, 2025EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Apr 22, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Apr 22, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 22, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Apr 17, 2025EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Apr 17, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Apr 17, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 17, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Feb 23, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Feb 23, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 23, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Feb 23, 2024CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Feb 23, 2024COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Oct 6, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 21, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 21, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 1, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 16, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 12, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 11, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 11, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 8, 2020GEANNOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED—
Jun 8, 2020GEAPEXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED—
Jun 8, 2020EPENCOMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY—
Jun 8, 2020CPEAEXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED—
Jun 2, 2020DOCKASSIGNED TO EXAMINER—
Mar 18, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 14, 2020NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance